October 9: Overnight Market Wrap

October 9: Overnight Market Wrap

Key Points:

Gilead releases more positive data on Remdesivir drug

US weekly jobless claims remain high at 840K from 820K expected

US equities stronger on fiscal stimulus hopes

US equities continued the rebound from Tuesdays fallout on new hopes of stimulus agreement but feedback from today’s talks and comments from Mitch McConnell shows that both parties are still a long way apart and the Democrats are unwilling to sanction a ‘skinny’ deal. FX trod water for most of the day with most currencies not far from yesterday’s levels and the DXY closing at the same level as we await the next push. However, the commodity currencies remained buoyant and CAD outperformed as WTI rallied over 3%. Weekly jobless claims came in higher at 840k vs 820k expected but made little impact with the key knee jerk volatility centered around fiscal stimulus comments. Trump continues to be erratic confirming that he will not take part in a virtual debate next week throwing into doubt whether it will happen or not but Biden has penciled in a Town Hall in Philadelphia in order to remain in the public eye. For the upcoming session we will see Chinese Caixin Service PMI data and the RBA’s Financial Stability Review however news out just now that Gilead is seeing an improvement in recovery in Covid testing has given stock futures a boost and likely to dictate price action ahead. In Europe we get some a data dump from the UK before Canadian employment data to close out the week.

Trade the global markets with a broker that has integrity, honesty and transparency at its core

This website is owned and operated by the Ox Securities group of companies, which include:
Ox Securities Pty Ltd registered address Level 37, 1 Macquarie Place, Sydney NSW 2000 Australia. AFSL 438402 ACN 163 551 602
Ox Securities Limited (SV) registered address Suite 305, Griffith Corporate Centre, Beachmont, Kingstown, St Vincent and the Grenadines
Risk Warning: The information contained on this website is general in nature and does not constitute advice or a recommendation to act upon the information or an offer. The information on this website does not take into account your personal objectives, circumstances, financial situations or needs. You are strongly recommended to seek independent professional advice before opening an account with us and/or acquiring our services/products. Ox Securities Limited (SV) do not accept applications from residents of the United States of America and Australia
Before you decide whether or not to invest any products referred to on this website, being over the counter (OTC) derivatives, it is important for you to read and consider our Financial Services Guide (FSG), Product Disclosure Statement (PDS), and Terms and Conditions (T&C), and ensure that you fully understand the risks involved. Fees, charges and commissions apply. OTC derivatives, including margin foreign exchange contracts and contract for differences, are leveraged products that carry a high level of risk to your capital. Trading is not suitable for everyone. You may incur losses that are substantially greater than your initial investment. You do not own, or have any rights to, the underlying assets which the OTC derivative is referring to. You should only trade with money you can afford to lose. There are also risks associated with online trading including, but not limited to, hardware and/or software failures, and disruptions to communication systems and internet connectivity.

Copyright © OxSecurities 2020. All rights reserved